Forendo Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Forendo Pharma Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11285
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フィンランド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Forendo Pharma Ltd (Forendo Pharma) is a drug development company that concentrates on tissue specific regulation of sex hormone effects. The company’s product pipeline include fispemifene, which is in clinical phase II development and intended for the treatment of lower urinary tract symptoms and chronic prostatitis; and HSD17B1-inhibitor program, which is intended for the treatment of endometriosis. It receives funding from various capital ventures to develop new drug programs. The company collaborates with academic partners in Finland and global external partners. Forendo Pharma is headquartered in Turku, Finland.

Forendo Pharma Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Forendo Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Forendo Pharma Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Forendo Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Forendo Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Forendo Pharma Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Forendo Pharma Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Forendo Pharma Acquires Two Programs from Hormos Medical 10
Venture Financing 11
Forendo Pharma Raises Additional USD4.6 Million in Series A Venture Financing 11
Forendo Pharma Raises USD15.3 Million in Series A Venture Financing 12
Forendo Pharma Raises Funds In First Round Of Venture Financing 14
Licensing Agreements 15
Apricus Biosciences Enters into Licensing Agreement with Forendo Pharma for Fispemifene 15
Forendo Pharma Ltd – Key Competitors 17
Forendo Pharma Ltd – Key Employees 18
Forendo Pharma Ltd – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Corporate Communications 20
Mar 07, 2018: David Colpman Joins the Board of Directors of Forendo Pharma 20
Mar 07, 2018: Karolinska Development’s portfolio company Forendo Pharma announces the appointment of David Colpman to its Board of Directors 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Forendo Pharma Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Forendo Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Forendo Pharma Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Forendo Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Forendo Pharma Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Forendo Pharma Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Forendo Pharma Acquires Two Programs from Hormos Medical 10
Forendo Pharma Raises Additional USD4.6 Million in Series A Venture Financing 11
Forendo Pharma Raises USD15.3 Million in Series A Venture Financing 12
Forendo Pharma Raises Funds In First Round Of Venture Financing 14
Apricus Biosciences Enters into Licensing Agreement with Forendo Pharma for Fispemifene 15
Forendo Pharma Ltd, Key Competitors 17
Forendo Pharma Ltd, Key Employees 18
Forendo Pharma Ltd, Other Locations 19

List of Figures
Forendo Pharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Forendo Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Forendo Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Forendo Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Forendo Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Forendo Pharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Forendo Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Forendo Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Forendo Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Better Drinks Co Limited:企業の戦略・SWOT・財務情報
    The Better Drinks Co Limited - Strategy, SWOT and Corporate Finance Report Summary The Better Drinks Co Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Incitec Pivot Ltd (IPL):企業の財務・戦略的SWOT分析
    Incitec Pivot Ltd (IPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • AVI Limited:企業の戦略・SWOT・財務情報
    AVI Limited - Strategy, SWOT and Corporate Finance Report Summary AVI Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Prescient Therapeutics Ltd (PTX):企業の財務・戦略的SWOT分析
    Summary Prescient Therapeutics Ltd (Prescient Therapeutics), formerly Virax Holdings Ltd, is a biotechnology company which develops novel medicines for cancer treatment. The company is investigating OmniCAR, an immune receptor platform that controls T-cell activity and multi-antigen targeting with a …
  • Arm Cement Plc:企業の戦略・SWOT・財務情報
    Arm Cement Plc - Strategy, SWOT and Corporate Finance Report Summary Arm Cement Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Extraction Oil & Gas Inc (XOG):企業の財務・戦略的SWOT分析
    Extraction Oil & Gas Inc (XOG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Safe Orthopaedics SA (SAFOR)-医療機器分野:企業M&A・提携分析
    Summary Safe Orthopaedics SA (Safe Orthopaedics) is medical equipment company that manufactures and markets minimally invasive devices for spinal surgery. The company’s product portfolio includes implants and surgical instruments. It offers modular cervical cages, percutaneous auto-correction screws …
  • MYR Group Inc (MYRG):企業の財務・戦略的SWOT分析
    Summary MYR Group Inc (MYR Group) is an electrical contractor that provides specialty contracting services for industrial, commercial, and electrical infrastructure markets. The company operates substations, transmission lines, and distribution systems. It offers services such as distribution constr …
  • Grant Thornton International Ltd:企業の戦略的SWOT分析
    Grant Thornton International Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • TV Asahi Corporation (9409):企業の財務・戦略的SWOT分析
    TV Asahi Corporation (9409) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Tiziana Life Sciences Plc (TILS):医療機器:M&Aディール及び事業提携情報
    Summary Tiziana Life Sciences Plc (Tiziana), formerly Alexander David Investments Plc, is a clinical stage biotechnology company that discovers and develops drugs to treat diseases in oncology and immunology. The company’s lead product candidate, TZLS-201, intended for the treatment of thymic carcin …
  • Elite Surgical Supplies (Pty) Ltd:製品パイプライン分析
    Summary Elite Surgical Supplies (Pty) Ltd (Elite Surgical) is a medical device company that manufactures and distributes surgical instruments. The company provides spinal, arthoplasty and consumable surgical instruments. Its spinal products include stand alone equipment, cervical cage, boiling VBR, …
  • Globe Telecom Inc (GLO):企業の財務・戦略的SWOT分析
    Globe Telecom Inc (GLO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • EnQuest Plc (ENQ):石油・ガス:M&Aディール及び事業提携情報
    Summary EnQuest Plc (EnQuest) is an independent oil and gas exploration and production company. The company’s assets include producing oil fields, portfolio of discoveries, and new developments. Its oil and gas exploration assets are located in the UK North Sea and also have presence in oil basins o …
  • RPM International Inc:企業の戦略・SWOT・財務情報
    RPM International Inc - Strategy, SWOT and Corporate Finance Report Summary RPM International Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Amarantus Bioscience Holdings Inc:企業のM&A・事業提携・投資動向
    Amarantus Bioscience Holdings Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Amarantus Bioscience Holdings Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • AnaMar AB-医療機器分野:企業M&A・提携分析
    Summary AnaMar AB (AnaMar), a subsidiary of Koncentra Holding AB, discovers, develops and commercializes therapeutic strategies to treat debilitating inflammation, fibrosis and pain. The company develops drug candidates from several chemical classes that concentrates on the receptors and shows poten …
  • Petroleo Brasileiro SA (PETR4):電力:M&Aディール及び事業提携情報
    Summary Petroleo Brasileiro SA (Petrobras) is an integrated oil and gas company. Its major businesses include exploration and production, refining, marketing, trade and transportation of oil and gas. The company also conducts biofuel, petrochemical, natural gas, electricity and chemical businesses, …
  • ImmusanT Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary ImmusanT Inc (ImmusanT) is a clinical stage biotechnology company that discovers, develops and delivers peptide-based immune therapies for the treatment of patients with autoimmune diseases. The company develops its therapeutic vaccines using its epitope-specific immuno-therapy (ESIT) platfo …
  • Geisinger Health System-医療機器分野:企業M&A・提携分析
    Summary Geisinger Health System (GHS) is an integrated health services organization that provides medical and surgical specialties and sub-specialties, and related health services. It offers a range of medical services for patients suffering from diseases related to cardiology, ENT, gastroenterology …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆